Advertisement

Idoxuridine or How It All Began

  • W. H. Prusoff
Part of the Developments in Medical Virology book series (DIMV, volume 3)

Abstract

“In the beginning God created Heaven and the Earth and the Earth was without form and void and darkness was upon the face of the deep ... Then God said: Let there be Light and there was Light” (1).

Keywords

Vaccinia Virus Thymidine Kinase Antiviral Drug Antiviral Agent Orotic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    “Genesis. The First Book of Moses”, p. 1.Google Scholar
  2. 2.
    Encyclopaedia Britannica 10: 893–911, 1981.Google Scholar
  3. 3.
    Potter, V.R. Nucleic Acid Outlines 1: 3–22, 1960.Google Scholar
  4. 4.
    Avery, O.T., MacLeod, C.M. and McCarty, M. J. Exp. Med. 79: 137–157, 1944.PubMedCrossRefGoogle Scholar
  5. 5.
    Hershey, A.D. and Chase, M. J. Gen. Physiol. 36: 39–56, 1953.CrossRefGoogle Scholar
  6. 6.
    Michelson, A.M. The Chemistry of Nucleosides and Nucleotides, Academic Press, New York, 1963, pp. 54–58.Google Scholar
  7. 7.
    Brown, D.J. The Pyrimidines, Interscience, 1962.Google Scholar
  8. 8.
    Brown, D.J. The Pyrimidine, Suppl. 1, Interscience, 1970.Google Scholar
  9. 9.
    Elion, G.B. and Hitchings, G.H. In: Advances in Chemotherapy (Eds. A. Coldin, F. Hawking and R.J. Schnitzer), Academic Press, New York, vol. 2, 1965, pp. 91–177.Google Scholar
  10. 10.
    Prusoff, W.H., Cheng, Y.-C. and Neenan, J. In: Progress in Chemotherapy 2 (Ed. G.K. Daikos), Hellenic Soc. Chemother., Athens, Greece, 1974, pp. 881–898.Google Scholar
  11. 11.
    Hitchings, G.H., Elion, G.B., Falco, E.A., Russell, P.B., Sherwood, M.B. and Vanderwerff, H. J. Biol. Chem. 183: 1–9, 1950.Google Scholar
  12. 12.
    Hitchings, G.H., Elion, G.B., Falco, E.A. and Vanderwerff, H.V. Ann. N.Y. Acad. Sci. 52: 1318–1335, 1950.PubMedCrossRefGoogle Scholar
  13. 13.
    Welch, A.D. Cancer Res. 21: 1475–1490, 1961.PubMedGoogle Scholar
  14. 14.
    Elion, G.B. and Hitchings, G.H. In: Advances in Chemotherapy (Eds. A. Goldin, F. Hawking and R.J. Schnitzer), Academic Press, New York, vol. 2, 1965, pp. 130–137.Google Scholar
  15. 15.
    Thompson, R.L., Wilkin, M.L., Hitchings, G.H., Elion, G.B., Falco, E.A. and Russell, P.B. Science 110: 454, 1949.PubMedCrossRefGoogle Scholar
  16. 16.
    Thomson, R.L., Price, M.L., Minton, S.A. Jr., Elion, G.B. and Hitchings, G.H. J. Immunol. 65: 529–534, 1950.Google Scholar
  17. 17.
    Herrmann, E.C. Jr. (Ed.) Ann. N.Y. Acad. Sci. 130: 1–482, 1965; 173: 1–844, 1970; 284: 1–720, 1977.Google Scholar
  18. 18.
    Matthews, R.E.F. Pharmacol. Rev. 10: 359–406, 1958.PubMedGoogle Scholar
  19. 19.
    Sidwell, R.W. and Witkowski, J.T. In: Burger’s Medicinal Chemotherapy (Ed. M.E. Wolf), John Wiley & Sons Inc., 4th Ed., Part II, 1979, pp. 543–592.Google Scholar
  20. 20.
    Rapp, F. (Ed.) Herpesvirus. UCLA Symposia on Molecular and Cellular Biology, New Series. Alan R. Liss Inc., vol. 21, 1984.Google Scholar
  21. 21.
    De Clercq, E. and Walker, R.T. (Eds.). Targets for the Design of Antiviral Agents. Plenum Press, New York, 1984.Google Scholar
  22. 22.
    Galasso, G.J., Merigan, T.C. and Buchanan, R.A. (Eds.). Antiviral Agents and Viral Diseases of Man. Raven Press, New York, 1984.Google Scholar
  23. 23.
    Becker, Y. (Ed.). Antiviral Drugs and Interferon: The Molecular Basis of Their Activity. Martinus Nijhoff, Boston, 1984.Google Scholar
  24. 24.
    Shugar, D. (ed.). Viral Chemotherapy. Vol. 1. Pergamon Press, Oxford, 1984.Google Scholar
  25. 25.
    Larder, B.A. and Darby G. Antiviral Res. 4: 1–42, 1984.PubMedCrossRefGoogle Scholar
  26. 26.
    Darby, G. and Field, H.J. Pharmacol. Ther. 23: 217–251, 1984.CrossRefGoogle Scholar
  27. 27.
    De Clercq, E. Biochem. Pharmacol. 33: 2159–2169, 1984.PubMedCrossRefGoogle Scholar
  28. 28.
    Brown, F. Ann. Rev. Microbiol. 38: 221–235, 1984.CrossRefGoogle Scholar
  29. 29.
    Whitley, R.J. J. Antinicrob. Chemother. 14, Suppl. A: 57–74, 1984.Google Scholar
  30. 30.
    Watson, R.J. and Enquist, L.W. Prog. Med. Virol. 31: 84–108, 1984.Google Scholar
  31. 31.
    Prusoff, W.H., Zucker, M., Mancini, W.R., Otto, M.J., Lin, T.-S. and Lee, J.J. Antiviral Res. Suppl. 1: 1–10, 1985.Google Scholar
  32. 32.
    Dolin, R. Science 227: 1296–1303, 1985.PubMedCrossRefGoogle Scholar
  33. 33.
    Oxford, J.S. and Oberg, B. (Eds.) Conquest of Viral Diseases — A Topical Review of Drugs and Vaccines. Elsevier Sci. Publ., 1985.Google Scholar
  34. 34.
    Mitsuya, H., Weinhold, K.J., Furman, P.A., St. Clair, M.H., Nusinoff Lehrman, S., Gallo, R.C., Bolognesi, D., Barry, D.W. and Broder, S. Proc. Natl. Acad. Sci. USA 82: 7096–7100, 1985.PubMedCrossRefGoogle Scholar
  35. 35.
    Pratt, W.B. and Fekety, R. (Eds.), The Antimicrobial Drugs. Oxford University Press, Oxford, 1986.Google Scholar
  36. 36.
    Robins, R.K., Chemical and Engineering News, Jan. 27: 28–40, 1986.Google Scholar
  37. 37.
    De Clercq, E. J. Med. Chem. 29: 1561–1569, 1986.PubMedCrossRefGoogle Scholar
  38. 38.
    Prusoff, W.H., Lin, T.-S. and Zucker, M. Antiviral Res. 6: 311–328, 1986.PubMedCrossRefGoogle Scholar
  39. 39.
    Bauer, D.J. Brit. Med. Bull. 41: 309–314, 1985.Google Scholar
  40. 40.
    Prusoff, W.H. Pharmacol. Rev. 19: 209–250, 1967.Google Scholar
  41. 41.
    Brownlee, K.A. and Hamre, D.A. J. Bacteriol. 61: 127–134, 1951.PubMedGoogle Scholar
  42. 42.
    Thompson, R.L., Minton, S.A. Jr., Officer, J.E. and Hitchings, G.H. J. Immunol. 70: 229–234, 1953.PubMedGoogle Scholar
  43. 43.
    Bauer, D.J. Brit. J. Exp. Pathol. 36: 105–114, 1955.Google Scholar
  44. 44.
    Bauer, D.J., St. Vincent, L.S., Kempe, C.H. and Downie, A.W. Lancet ii: 494–496, 1963.CrossRefGoogle Scholar
  45. 45.
    Bauer, D.J. Ann. N.Y. Acad. Sci. 130: 110–117, 1965.PubMedCrossRefGoogle Scholar
  46. 46.
    Hansson, O., Johansson, S.G.O. and Vahlquist, B. Acta Paediatr. Scand. 55: 264–272, 1966.PubMedCrossRefGoogle Scholar
  47. 47.
    Johnson, T.B. and Johns, C.O. J. Biol. Chem. 1: 305–318, 1905–06.Google Scholar
  48. 48.
    Hitchings, G.H., Falco, E.A. and Sherwood, M.B. Science 102: 251–252, 1945.PubMedCrossRefGoogle Scholar
  49. 49.
    Dunn, D.B. and Smith, J.D. Biochem. J. 67: 494–506, 1957.PubMedGoogle Scholar
  50. 50.
    Dunn, D.B., Smith, J.D., Zamenhof, S. and Griboff, G. Nature 174: 305–307, 1954.PubMedCrossRefGoogle Scholar
  51. 51.
    Luzzati, D. Compt. Rend. Acad. Sci. 245: 1466–1468, 1957.Google Scholar
  52. 52.
    Zamenhof, S. and Griboff, G. Nature 174: 307–308, 1954.PubMedCrossRefGoogle Scholar
  53. 53.
    Prusoff, W.H., Holmes, W.L. and Welch, A.D. Cancer Res. 13: 221–225, 1953.PubMedGoogle Scholar
  54. 54.
    Plentle, A.A. and Schoenheimer, R. J. Eiol. Chem. 153: 203–217, 1944.Google Scholar
  55. 55.
    Holmes, W.L., Prusoff, W.H. and Welch, A.D. J. Biol. Chem. 209: 503–509, 1954.PubMedGoogle Scholar
  56. 56.
    Brown, G.B., Roll, P.M. and Weinfield, H. In: Phosphorous Metabolism (Eds. W.A. McElroy and B. Glass), Johns Hopkins Press, Baltimore, 1952, p. 388.Google Scholar
  57. 57.
    Reichard, R. Acta Chem. Scand. 9: 1275–1285, 1956.CrossRefGoogle Scholar
  58. 58.
    Prusoff, W.H. Biochim. Biophys. Acta 32: 295–296, 1959.PubMedCrossRefGoogle Scholar
  59. 59.
    Mathias, A.P. Fischer, G.A. and Prusoff, W.H. Biochim. Biophys. Acta 36: 560–561, 1959.PubMedCrossRefGoogle Scholar
  60. 60.
    Prusoff, W.H. Fed. Proc. 18: 305, 1959.Google Scholar
  61. 61.
    Eidinoff, M.L., Cheong, L., Gambetta Gurpide, E., Benua, R.S. and Ellison, R.R. Nature 183: 1686–1687, 1959.PubMedCrossRefGoogle Scholar
  62. 62.
    Eidinoff, M.L., Cheong, L. and Rich, M.A. Science 129: 1550–1551, 1959.PubMedCrossRefGoogle Scholar
  63. 63.
    Eidinoff, M.L., Cheong, L. and Rich, M.A. Fed. Proc. 18: 220, 1959.Google Scholar
  64. 64.
    Prusoff, W.H. Cancer Res. 20: 92–95, 1960.PubMedGoogle Scholar
  65. 65.
    Herrmann, E.C. Jr. Proc. Soc. Exp. Biol. 107: 142–145, 1961.Google Scholar
  66. 66.
    Rada, B., Blaskovic, D., Sorm, F. and Skoda, J. Experientia 16: 487–488, 1960.PubMedCrossRefGoogle Scholar
  67. 67.
    Smith, J.D., Freeman, G., Vogt, M. and Dulbecco, R. Virology 12: 185–196, 1960.CrossRefGoogle Scholar
  68. 68.
    Kaufman, H.E. Personal communication.Google Scholar
  69. 69.
    Perkins, E.S., Wood, R.M., Sears, M.L., Prusoff, W.H. and Welch, A.D. Nature 194: 985–986, 1962.PubMedCrossRefGoogle Scholar
  70. 70.
    Kaufman, H.E. Proc. Soc. Exp. Biol. Med. 109: 251–252, 1962.PubMedGoogle Scholar
  71. 71.
    Kaufman, H.E., Martola, E.-L. and Dohlman, C. Arch. Ophthalmol. 68: 235–239, 1962.PubMedGoogle Scholar
  72. 72.
    Kaufman, H.E., Nesburn, A.B. and Maloney, E.D. Arch. Ophthalmol. 68: 583–591, 1962.Google Scholar
  73. 73.
    Calabresi, P., Cardoso, S.S., Finch, S.C., Kligerman, M.M., von Essen, CF., Chu, M.Y. and Welch, A.D. Cancer Res. 21: 550–559, 1961.PubMedGoogle Scholar
  74. 74.
    Fischer, P.H., Chen, M.S. and Prusoff, W.H. Biochim. Biophys. Acta 606: 236–245, 1980.PubMedGoogle Scholar
  75. 75.
    Otto, M.J., Lee, J.J. and Prusoff, W.H. Antiviral Res. 2: 267–281, 1982.PubMedCrossRefGoogle Scholar
  76. 76.
    Otto, M.J., Goz, B. and Prusoff, W.H. In: Antiviral Drugs and Interferon: The Molecular Basis of Their Activities (Ed. J. Becker), Martinus Nijhoff, Boston, 1984, pp. 11–38.Google Scholar
  77. 77.
    Zucker, M.L., Mancini, W.R., Otto, M.J., Shim Lee, J.-J. and Prusoff, W.H. Antiviral Res. 6: 69–81, 1986.PubMedCrossRefGoogle Scholar
  78. 78.
    Prusoff, W.H., Mancini, W.R., Lin, T.-S., Lee, J.J., Siegel, S.A. and Otto, M.J. Antiviral Res. 4: 303–315, 1984.PubMedCrossRefGoogle Scholar
  79. 79.
    Goz, B. and Prusoff, W.H. J. Biol. Chem. 243: 4750–4756, 1968.PubMedGoogle Scholar
  80. 80.
    Goz, B. and Prusoff, W.H. Ann. N.Y. Acad. Sci. 173: 379–389, 1970.CrossRefGoogle Scholar
  81. 81.
    Goz, B. Pharmacol. Rev. 29: 249–272, 1978.Google Scholar
  82. 82.
    Boston Interhospital Virus Study Group and the NIAID-Sponsored Cooperative Antiviral Clinical Study. New Engl. J. Med. 292: 599–603, 1975.CrossRefGoogle Scholar
  83. 83.
    Juel-Jensen, B.E. Brit. Med. J. i: 406–410, 1973.CrossRefGoogle Scholar
  84. 84.
    Juel-Jensen, B.E. Practioner 213: 508–518, 1974.Google Scholar

Copyright information

© Martinus Nijhoff Publishing 1988

Authors and Affiliations

  • W. H. Prusoff
    • 1
  1. 1.Department of Pharmacology, School of MedicineYale UniversityNew HavenUSA

Personalised recommendations